ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma

BACKGROUNDS: Standard of care for patients with primary CNS lymphoma (PCNSL) has been high-dose methotrexate (HD-MTX)-based multiagent immunochemotherapy, particularly with R-MPV-A with or without whole-brain radiotherapy (WBRT), however, the optimal treatment for relapsed/refractory (r/r)PCNSL has...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurooncol Adv
Main Authors: Nagane, Motoo, Sasaki, Nobuyoshi, Kobayashi, Keiichi, Saito, Kuniaki, Shimada, Daisuke, Matsumoto, Yoshie, Iijima, Shohei, Yamagishi, Yuki, Shimizu, Saki, Sasaki, Yuta, Shiokawa, Yoshiaki
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Supplement Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699036/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.066
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki